These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2029695)

  • 1. Effects of levodopa and bromocriptine on blood pressure and plasma catecholamines in parkinsonians.
    Durrieu G; Senard JM; Tran MA; Rascol A; Montastruc JL
    Clin Neuropharmacol; 1991 Feb; 14(1):84-90. PubMed ID: 2029695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood pressure and plasma catecholamines in never-treated parkinsonian patients: effect of a selective D1 agonist (CY 208-243).
    Durrieu G; Senard JM; Rascol O; Tran MA; Lataste X; Rascol A; Montastruc JL
    Neurology; 1990 Apr; 40(4):707-9. PubMed ID: 2320249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levodopa, bromocriptine and selegiline modify cardiovascular responses in Parkinson's disease.
    Haapaniemi TH; Kallio MA; Korpelainen JT; Suominen K; Tolonen U; Sotaniemi KA; Myllylä VV
    J Neurol; 2000 Nov; 247(11):868-74. PubMed ID: 11151420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study of dopaminergic sensitivity in Parkinson's disease: comparison in "de novo" and levodopa-treated patients.
    Llau ME; Durrieu G; Tran MA; Senard JM; Rascol O; Montastruc JL
    Clin Neuropharmacol; 1996 Oct; 19(5):420-7. PubMed ID: 8889285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired cardiovascular autonomic control in newly and long-term-treated patients with Parkinson's disease: involvement of L-dopa therapy.
    Bouhaddi M; Vuillier F; Fortrat JO; Cappelle S; Henriet MT; Rumbach L; Regnard J
    Auton Neurosci; 2004 Nov; 116(1-2):30-8. PubMed ID: 15556835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of acute levodopa administration on blood pressure and heart variability in never treated parkinsonians.
    Sénard JM; Verwaerde P; Rascol O; Montastruc JL
    Hypertens Res; 1995 Jun; 18 Suppl 1():S175-7. PubMed ID: 8529054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular control and plasma catecholamines during rest and mental stress: effects of posture.
    Tulen JH; Boomsma F; Man in 't Veld AJ
    Clin Sci (Lond); 1999 Jun; 96(6):567-76. PubMed ID: 10334962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of dopamine agonists on human cardiovascular and sympathetic nervous systems.
    Ziegler MG; Kennedy B; Holland OB; Murphy D; Lake CR
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23(4):175-9. PubMed ID: 3158615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of different dopaminergic antagonists on bromocriptine-induced inhibition of norepinephrine release.
    Mannelli M; Delitala G; De Feo ML; Maggi M; Cuomo S; Piazzini M; Guazzelli R; Serio M
    J Clin Endocrinol Metab; 1984 Jul; 59(1):74-8. PubMed ID: 6725527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Side-effects of L-dopa on venous tone in Parkinson's disease: a leg-weighing assessment.
    Wolf JP; Bouhaddi M; Louisy F; Mikehiev A; Mourot L; Cappelle S; Vuillier F; Andre P; Rumbach L; Regnard J
    Clin Sci (Lond); 2006 Mar; 110(3):369-77. PubMed ID: 16302846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-adrenergic sensitivity in Parkinson's disease: effect of levodopa treatment.
    Durrieu G; Rispail Y; Chatelut E; Berlan M; Rascol A; Montastruc JL; Montastruc P
    Clin Neuropharmacol; 1990 Dec; 13(6):492-9. PubMed ID: 2177376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combined treatment of the early stages of Parkinson's syndrome with bromocriptine and levodopa. The results of a multicenter study].
    Fischer PA; Przuntek H; Majer M; Welzel D
    Dtsch Med Wochenschr; 1984 Aug; 109(34):1279-83. PubMed ID: 6381019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum noradrenaline response to standing up in patients with Parkinson's disease.
    Turkka JT; Juujärvi KK; Lapinlampi TO; Myllylä VV
    Eur Neurol; 1986; 25(5):355-61. PubMed ID: 3780779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of bromocriptine on plasma catecholamine concentrations in normal volunteers.
    Steardo L; Di Stasio E; Bonuso S; Maj M
    Eur J Clin Pharmacol; 1986; 29(6):713-5. PubMed ID: 3709615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of bromocriptine for testing central dopaminergic reactivity.
    Allain H; Reymann JM; Bentue-Ferrer D; Pape D; van den Driessche J; Sabouraud O
    Psychopharmacology (Berl); 1980; 70(3):313-5. PubMed ID: 6777808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levodopa therapy in Parkinson's disease: influence on liquid chromatographic tandem mass spectrometric-based measurements of plasma and urinary normetanephrine, metanephrine and methoxytyramine.
    Eisenhofer G; Brown S; Peitzsch M; Pelzel D; Lattke P; Glöckner S; Stell A; Prejbisz A; Fassnacht M; Beuschlein F; Januszewicz A; Siegert G; Reichmann H
    Ann Clin Biochem; 2014 Jan; 51(Pt 1):38-46. PubMed ID: 23873873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of acute loading with levodopa and levodopa with selegiline on blood pressure and plasma norepinephrine levels in chronic Parkinson's disease patients.
    Stryjer R; Klein C; Treves TA; Rabey JM
    Acta Neurol Scand; 2005 Feb; 111(2):89-94. PubMed ID: 15644067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenergic supersensitivity in parkinsonians with orthostatic hypotension.
    Senard JM; Valet P; Durrieu G; Berlan M; Tran MA; Montastruc JL; Rascol A; Montastruc P
    Eur J Clin Invest; 1990 Dec; 20(6):613-9. PubMed ID: 1964123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bromocriptine reduces plasma noradrenaline and 3,4-dihydroxyphenylacetic acid in normal and hypotensive subjects.
    Mercuro G; Rossetti ZL; Tocco L; Rivano CA; Cherchi A; Gessa GL
    Eur J Clin Pharmacol; 1985; 27(6):671-5. PubMed ID: 3987772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autonomic nervous function in de novo parkinsonian patients in basal condition and after acute levodopa administration.
    Quadri R; Comino I; Scarzella L; Cacioli P; Zanone MM; Pipieri A; Bergamasco B; Chiandussi L
    Funct Neurol; 2000; 15(2):81-6. PubMed ID: 10916719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.